e-learning
resources
Madrid 2019
Monday, 30.09.2019
Identification of new targets and therapeutic strategies for lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of Tacrolimus in the epithelial-mesenchymal transition in chronic lung allograft dysfonction
M. Gracyasz (Strasbourg, France), K. Vallière (Strasbourg, France), A. El Habhab (Strasbourg, France), B. Renaud-Picard (Strasbourg, France), F. El-Ghazouani (Strasbourg, France), L. Kessler (Strasbourg, France), F. Toti (Strasbourg, France), R. Kessler (Strasbourg, France)
Source:
International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Session:
Identification of new targets and therapeutic strategies for lung disease
Session type:
Thematic Poster
Number:
2358
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gracyasz (Strasbourg, France), K. Vallière (Strasbourg, France), A. El Habhab (Strasbourg, France), B. Renaud-Picard (Strasbourg, France), F. El-Ghazouani (Strasbourg, France), L. Kessler (Strasbourg, France), F. Toti (Strasbourg, France), R. Kessler (Strasbourg, France). Impact of Tacrolimus in the epithelial-mesenchymal transition in chronic lung allograft dysfonction. 2358
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Epithelial-mesenchymal transition in chronic lung allograft dysfunction. Role of leucocyte microparticles
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Bronchiolitis obliterans formation by epithelial-mesenchymal transition in lung transplant recipients
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Evaluation of lung mechanics and the progression of disease in acute allograft rejection after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
A role for the mesothelium in restrictive chronic lung allograft dysfunction?
Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD)
Year: 2017
Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Electronic nose for detecting chronic lung allograft dysfunction in lung transplant recipients
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021
Pronounced neutrophil-rich inflammation in induced sputum of lung transplant recipients with chronic rejection
Source: Eur Respir J 2001; 18: Suppl. 33, 297s
Year: 2001
Pirfenidone stabilizes pulmonary function and reduces
18
F-FDG-uptake in restrictive allograft syndrome following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
A model of chronic lung allograft rejection in the rat
Source: Eur Respir J 2010; 35: 1354-1363
Year: 2010
Assessment of the restrictive allograft syndrome in patients after lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
A new biomarker for chronic lung allograft dysfunction
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014
Impact of mycophenolate mofetil on lung function in chronic hypersensitivity pneumonitis and connective tissue disease related-ILD
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Rapamycin in patients with chronic lung rejection
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011
Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018
Anti-reflux surgery for gastroesophageal reflux disease after lung transplantation: Benefit for lung function, acute rejections and respiratory infections
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015
KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept